Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 25 of 241
Opening Ceremony
Opening Remarks
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
President's Remarks
José Baselga
Memorial Sloan Kettering Cancer Center, New York, NY
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Introduction of Inaugural Recipients of the AACR NextGen Grants for Transformative Cancer Research
Recipients: Paul A. Northcott, Andrew C. Hsieh, Sophia Y. Lunt, and Nikhil Wagle
St. Jude Children's Research Hospital, Memphis, TN; Fred Hutchinson Cancer Research Center, Seattle, WA; Michigan State University, East Lansing, MI; Dana-Farber Cancer Institute, Boston, MA
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Recognition of the Fellows of the AACR Academy
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Tenth Annual AACR Team Science Award Presentation
Recipients: Women's Health Initiative Team— Ross Prentice and Garnet Anderson
Fred Hutchinson Cancer Research Center, Seattle, WA
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Thirteenth Annual AACR Award for Lifetime Achievement in Cancer Research Presentation
Recipient: Robert A. Weinberg
Massachusetts Institute of Technology, Cambridge, MA
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Tenth AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Presentation
Recipient: Waun Ki Hong
University of Texas MD Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Presentation of the Inaugural AACR June L. Biedler Prizes for Cancer Journalism
Recipients: Todd Ackerman; Tom Junod; Debbie Galant and Noah Levinson; Kay Colby
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
2015 AACR Distinguished Public Service Award Presentation
Recipient: Mary Jackson Scroggins
In My Sister's Care, Washington, DC
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Ceremony
Video Tribute to Vice President Joe Biden
José Baselga
Memorial Sloan Kettering Cancer Center, New York, NY
from AACR Annual Meeting 2016 on April 17, 2016 8:15 AM-9:15 AM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
Chairperson
Scott A. Armstrong
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
Cancer genomics: A translational future
Elaine R. Mardis
Washington University School Of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
Targeting epigenomic dependencies in cancer
James E. Bradner
Novartis, Cambridge, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
  •  
  • Permission not
    granted for presentation
  •  
  •  
Genome editing using CRISPR-Cas systems
Feng Zhang
Massachusetts Institute of Technology, Cambridge, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
T cell recognition of human cancer
Ton Schumacher
Netherlands Cancer Inst., Amsterdam, Netherlands
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Opening Plenary-- Breakthroughs in Cancer Research: Genomics, Epigenetics, and Immunomodulation
Stem cells and cancer
Elaine Fuchs
Howard Hughes Medical Institute/Rockefeller University, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 9:30 AM-12:00 PM
Immuno-oncology Clinical Trials I
Initial report of overall survival rates from a randomized phase II trial evaluating the combination of nivolumab (NIVO) and ipilimumab (IPI) in patients with advanced melanoma (MEL)
Michael Postow
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
Discussant
Padmanee Sharma
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
KEYNOTE-006: PD-L1 expression and efficacy in patients (Pts) treated with pembrolizumab (pembro) vs ipilimumab (IPI) for advanced melanoma
Matteo Carlino
Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Wentworthville, Australia
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
Discussant
Charles G. Drake
Johns Hopkins Kimmel Comp. Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
A phase I study of an HLA-DPB1*0401-restricted T-cell receptor targeting MAGE-A3 for patients with metastatic cancer
Yong-Chen Lu
National Institutes of Health, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
Durable, long-term survival in previously treated patients with advanced melanoma (MEL) who received nivolumab (NIVO) monotherapy in a phase I trial
F. Stephen Hodi
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Immuno-oncology Clinical Trials I
Discussant
Jedd D Wolchok
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:15 PM
Precision Medicine Early Clinical Trials
Phase I study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
Jayesh Desai
Royal Melbourne Hospital, Melbourne, Australia
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Precision Medicine Early Clinical Trials
Discussant
Udai Banerji
Inst. of Cancer Research, Sutton, United Kingdom
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Precision Medicine Early Clinical Trials
Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic MET mutations. EORTC phase II trial 90101 "CREATE"
Patrick Schoffski
University Hospitals Leuven - Department of General Medical Oncology, Leuven, Belgium
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 25 of 241